Cancer Prevention

Top Story

Hereditary cancer foundation launches Lynch Syndrome patient registry

February 10, 2016

AliveAndKickn has announced the launch of the HEROIC Registry, a genetic database for people with Lynch Syndrome to share data and further research, according to a press release.

Lynch Syndrome, a hereditary disorder caused by a mismatch repair gene mutation that increases risk for colorectal, endometrial and other (often early-onset) cancers, is a CDC Tier 1 public health initiative genetic mutation, according to the press release. It affects one in 440 Americans, but up to 95% are undiagnosed.

In the Journals

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs

February 8, 2016
Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping” — to prevent…

Expert: Guideline needed to limit consumption of red, processed meats

February 5, 2016
In October, WHO released data suggesting an association between red or processed meats and an increased risk for colorectal cancer.This report ― along with years of…
In the Journals

World Cancer Day: ‘We can’ reduce global cancer burden

February 4, 2016
Today marks the annual observation of World Cancer Day, founded by the Union for International Cancer Control to raise awareness of cancer and emphasize the importance…
CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
Video

VIDEO: Effort to systematize approach to medicine has ‘taken on a life of its own’

January 20, 2016
More »
Featured
CME

The Patient with Severe Leukocytosis

No commercial support for this activity.

Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML)…
More »

Hereditary cancer foundation launches Lynch Syndrome patient registry

February 10, 2016
AliveAndKickn has announced the launch of the HEROIC Registry, a genetic database for people with Lynch Syndrome to share data and further research…
In the Journals

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs

February 8, 2016
Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping”…

Expert: Guideline needed to limit consumption of red, processed meats

February 5, 2016
In October, WHO released data suggesting an association between red or processed meats and an increased risk for colorectal cancer.This report ―…
In the Journals

World Cancer Day: ‘We can’ reduce global cancer burden

February 4, 2016
Today marks the annual observation of World Cancer Day, founded by the Union for International Cancer Control to raise awareness of cancer and…

Memorial Sloan Kettering program focuses on cancer disparities among U.S. immigrants

February 1, 2016
Immigrants are considerably underserved in terms of health care in the United States. Memorial Sloan Kettering Cancer Center launched its Immigrant…
Breaking News

NCI-designated cancer centers call for increase in HPV vaccination

January 27, 2016
Sixty-nine NCI-designated cancer centers today issued a call for action to urge an increase in HPV vaccination rates for the prevention of cancer.The…

MD Anderson's Moon Shots program expands into new cancer types

January 25, 2016
Originally launched in 2013, The University of Texas MD Anderson Cancer Center’s Moon Shots Program recently expanded its campaign to…

UTHealth physician joins NCI board

January 23, 2016
Sally Vernon, PhD, chair of the department of health promotion and behavioral sciences at The University of Texas Health Science Center at Houston…
Video

VIDEO: Effort to systematize approach to medicine has ‘taken on a life of its own’

January 20, 2016
HemOnc Today’s Chief Medical Editors — Derek Raghavan, MD, PhD, and John Sweetenham, MD — discuss the proliferation of guidelines…
CME

The Patient with Severe Leukocytosis

January 15, 2016 Expires: 1/15/2017
Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML). Although imatinib has been the…
More Headlines »
morganatic-roan morganatic-roan